Patents by Inventor C. Cheng

C. Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170121254
    Abstract: Disclosed is a process for the conversion of acyclic C5 feedstock to a product comprising cyclic C5 compounds, such as for example, cyclopentadiene, and catalyst compositions for use in such process. The process comprising the steps of contacting said feedstock and, optionally, hydrogen under acyclic C5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprising a microporous crystalline ferrosilicate, a Group 10 metal, and, optionally, a Group 11 metal, in combination with an optional Group 1 alkali metal and/or an optional Group 2 alkaline earth metal.
    Type: Application
    Filed: October 7, 2016
    Publication date: May 4, 2017
    Inventors: Larry L. Iaccino, Jeremy W. Bedard, Wenyih F. Lai, Christopher M. Evans, Jane C. Cheng
  • Publication number: 20170121253
    Abstract: Disclosed is a process for the conversion of acyclic C5 feedstock to a product comprising cyclic C5 compounds, such as, for example, cyclopentadiene, and catalyst compositions for use in such process. The process comprises the steps of contacting said feedstock and, optionally, hydrogen under acyclic C5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprising a microporous crystalline aluminosilicate having a constraint index in the range of 3 to 12, a Group 10 metal, and, optionally, a Group 11 metal, in combination with a Group 1 alkali metal and/or a Group 2 alkaline earth metal.
    Type: Application
    Filed: October 7, 2016
    Publication date: May 4, 2017
    Inventors: Larry L. Iaccino, Jeremy W. Bedard, Wenyih F. Lai, Robert T. Carr, Jane C. Cheng
  • Publication number: 20170121245
    Abstract: Disclosed is a process for the conversion of acyclic C5 feedstock to a product comprising cyclic C5 compounds, such as for example, cyclopentadiene, and catalyst compositions for use in such process. The process comprising the steps of contacting said feedstock and, optionally, hydrogen under acyclic C5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprising a crystalline aluminosilicate having a constraint index of less than or equal to 5, and a Group 10 metal, and, optionally, a Group 11 metal, in combination with a Group 1 alkali metal and/or a Group 2 alkaline earth metal.
    Type: Application
    Filed: October 7, 2016
    Publication date: May 4, 2017
    Inventors: Larry L. Iaccino, Jeremy W. Bedard, Karl G. Strohmaier, Machteld M.W. Mertens, Robert T. Carr, Jane C. Cheng
  • Publication number: 20170111440
    Abstract: A computer-implemented method includes identifying a primary computing platform, identifying one or more secondary computing platforms, and identifying a requesting virtual server. The requesting virtual server resides on the primary computing platform and is associated with one or more requesting clients. One or more donating virtual servers are identified. The donating virtual servers reside on the primary computing platform and are associated with one or more donating clients. One or more external virtual servers are identified. The external virtual servers reside on the secondary computing platforms. A resource donation scenario is determined. The resource donation scenario includes one or more resource exchanges between the requesting virtual server and the donating virtual servers. A resource adjustment scenario is determined. The resource adjustment scenario includes one or more resource exchanges between the external virtual servers.
    Type: Application
    Filed: September 20, 2016
    Publication date: April 20, 2017
    Inventors: Victor G. Alonzo, Yuk L. Chan, Gisela C. Cheng, Kin Ng, Vaughn C. Page
  • Publication number: 20170111438
    Abstract: A computer-implemented method includes identifying a primary computing platform, identifying one or more secondary computing platforms, and identifying a requesting virtual server. The requesting virtual server resides on the primary computing platform and is associated with one or more requesting clients. One or more donating virtual servers are identified. The donating virtual servers reside on the primary computing platform and are associated with one or more donating clients. One or more external virtual servers are identified. The external virtual servers reside on the secondary computing platforms. A resource donation scenario is determined. The resource donation scenario includes one or more resource exchanges between the requesting virtual server and the donating virtual servers. A resource adjustment scenario is determined. The resource adjustment scenario includes one or more resource exchanges between the external virtual servers.
    Type: Application
    Filed: September 20, 2016
    Publication date: April 20, 2017
    Inventors: Victor G. Alonzo, Yuk L. Chan, Gisela C. Cheng, Kin Ng, Vaughn C. Page
  • Publication number: 20170111439
    Abstract: A computer-implemented method includes identifying a primary computing platform, identifying one or more secondary computing platforms, and identifying a requesting virtual server. The requesting virtual server resides on the primary computing platform and is associated with one or more requesting clients. One or more donating virtual servers are identified. The donating virtual servers reside on the primary computing platform and are associated with one or more donating clients. One or more external virtual servers are identified. The external virtual servers reside on the secondary computing platforms. A resource donation scenario is determined. The resource donation scenario includes one or more resource exchanges between the requesting virtual server and the donating virtual servers. A resource adjustment scenario is determined. The resource adjustment scenario includes one or more resource exchanges between the external virtual servers.
    Type: Application
    Filed: September 20, 2016
    Publication date: April 20, 2017
    Inventors: Victor G. Alonzo, Yuk L. Chan, Gisela C. Cheng, Kin Ng, Vaughn C. Page
  • Patent number: 9623263
    Abstract: Apparatus and methods for therapy delivery are disclosed. In one embodiment, a therapy delivery system includes a plurality of movable components including a radiation therapy nozzle and a patient pod for holding a patient, a patient registration module for determining a desired position of at least one of the plurality of movable components, and a motion control module for coordinating the movement of the least one of the plurality of movable components from a current position to the desired position. The motion control module includes a path planning module for simulating at least one projected trajectory of movement of the least one of the plurality of moveable components from the current position to the desired position.
    Type: Grant
    Filed: June 6, 2014
    Date of Patent: April 18, 2017
    Assignee: VISION RT LIMITED
    Inventors: Chieh C. Cheng, David A. Lesyna, Michael F. Moyers
  • Patent number: 9604203
    Abstract: Process for the preparation of a catalyst suitable for use in a naphtha reforming process, the process including providing a Y zeolite with an initial SiO2:Al2O3 molar ratio of at least 150, introducing the Y zeolite to a binder to form an intermediate composition, extruding the intermediate composition, reducing the alpha acidity of the extruded composition to provide a low acid composition, and introducing a noble metal to the low acid composition. Processes and systems of converting naphtha to a higher-octane hydrocarbon supply using catalysts, as prepared herein, are also disclosed.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: March 28, 2017
    Assignee: ExxonMobil Research and Engineering Company
    Inventors: Jean W. Beeckman, Stephen J. McCarthy, Jane C. Cheng
  • Publication number: 20170081378
    Abstract: This disclosure is related to the peptide antagonist of LL-37, an antimicrobial peptide that has multiple functions in both innate and adaptive immune response. Specifically, the identified peptide antagonists of LL-37 provide inhibition to detrimental autoimmune inflammatory response, whereas at the same time retain LL-37's antibacterial activity.
    Type: Application
    Filed: May 21, 2015
    Publication date: March 23, 2017
    Inventors: C. Cheng KAO, Divyendu SINGH, Lani Rose SAN MATEO
  • Patent number: 9573936
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: February 21, 2017
    Assignee: AMGEN INC.
    Inventors: Ning Chen, Xiaoqi Chen, Yinhong Chen, Alan C. Cheng, Richard V. Connors, Jeffrey Deignan, Paul John Dransfield, Xiaohui Du, Zice Fu, Julie Anne Heath, Daniel B. Horne, Jonathan Houze, Matthew R. Kaller, Aarif Yusuf Khakoo, David John Kopecky, Su-Jen Lai, Zhihua Ma, Lawrence R. McGee, Julio C. Medina, Jeffrey T. Mihalic, Nobuko Nishimura, Steven H. Olson, Vatee Pattaropong, Gayathri Swaminath, Xiaodong Wang, Kevin Yang, Wen-Chen Yeh, Mikkel V. Debenedetto, Robert P. Farrell, Simon J. Hedley, Ted C. Judd, Frank Kayser
  • Publication number: 20170042871
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
    Type: Application
    Filed: October 19, 2016
    Publication date: February 16, 2017
    Inventors: Ning Chen, Xiaoqi CHEN, Yinhong CHEN, Alan C. CHENG, Richard V. CONNORS, Jeffrey DEIGNAN, Paul John DRANSFIELD, Xiaohui DU, Zice FU, Julie Anne HEATH, Daniel B. HORNE, Jonathan HOUZE, Matthew R. KALLER, Aarif Yusuf KHAKOO, David John KOPECKY, Su-Jen LAI, Zhihua MA, Lawrence R. MCGEE, Julio C. MEDINA, Jeffrey T. MIHALIC, Nobuko NISHIMURA, Steven H. OLSON, Vatee PATTAROPONG, Gayathri SWAMINATH, Xiaodong WANG, Kevin YANG, Wen-Chen YEH, Mikkel V. DEBENEDETTO, Robert P. FARRELL, Simon J. HEDLEY, Ted C. JUDD, Frank KAYSER
  • Publication number: 20170042897
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 16, 2017
    Inventors: Ning Chen, Xiaoqi Chen, Yinhong Chen, Alan C. Cheng, Richard V. Connors, Jeffrey Deignan, Paul John Dransfield, Xiaohui Du, Zice Fu, Julie Anne Heath, Daniel B. Horne, Jonathan Houze, Matthew R. Kaller, Aarif Yusuf Khakoo, David John Kopecky, Su-Jen Lai, Zhihua Ma, Lawrence R. McGee, Julio C. Medina, Jeffrey T. Mihalic, Nobuko Nishimura, Steven H. Olson, Vatee Pattaropong, Gayathri Swaminath, Xiaodong Wang, Kevin Yang, Wen-Chen Yeh, Mikkel V. Debenedetto, Robert P. Farrell, Simon J. Hedley, Ted C. Judd, Frank Kayser
  • Publication number: 20170044131
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 16, 2017
    Inventors: Ning CHEN, Xiaoqi CHEN, Yinhong CHEN, Alan C. CHENG, Richard V. CONNORS, Jeffrey DEIGNAN, Paul John DRANSFIELD, Xiaohui DU, Zice FU, Julie Anne HEATH, Daniel B. HORNE, Jonathan HOUZE, Matthew R. KALLER, Aarif Yusuf KHAKOO, David John KOPECKY, Su-Jen LAI, Zhihua MA, Lawrence R. MCGEE, Julio C. MEDINA, Jeffrey T. MIHALIC, Nobuko NISHIMURA, Steven H. OLSON, Vatee PATTAROPONG, Gayathri SWAMINATH, Xiaodong WANG, Kevin YANG, Wen-Chen YEH, Mikkel V. DEBENEDETTO, Robert P. FARRELL, Simon J. HEDLEY, Ted C. JUDD, Frank KAYSER
  • Publication number: 20170042872
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
    Type: Application
    Filed: October 19, 2016
    Publication date: February 16, 2017
    Inventors: Ning CHEN, Xiaoqi CHEN, Yinhong CHEN, Alan C. CHENG, Richard V. CONNORS, Jeffrey DEIGNAN, Paul John DRANSFIELD, Xiaohui DU, Zice FU, Julie Anne HEATH, Daniel B. HORNE, Jonathan HOUZE, Matthew R. KALLER, Aarif Yusuf KHAKOO, David John KOPECKY, Su-Jen LAI, Zhihua Ma, Lawrence R. MCGEE, Julio C. MEDINA, Jeffrey T. MIHALIC, Nobuko NISHIMURA, Steven H. OLSON, Vatee PATTAROPONG, Gayathri SWAMINATH, Xiaodong WANG, Kevin YANG, Wen-Chen YEH, Mikkel V. DEBENEDETTO, Robert P. FARRELL, Simon J. HEDLEY, Ted C. Judd, Frank KAYSER
  • Publication number: 20170035744
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 9, 2017
    Inventors: Ning CHEN, Xiaoqi CHEN, Yinhong CHEN, Alan C. CHENG, Richard V. CONNORS, Jeffrey DEIGNAN, Paul John DRANSFIELD, Xiaohui DU, Zice FU, Julie Anne HEATH, Daniel HORNE, Jonathan HOUZE, Matthew R. KALLER, Aarif Yusuf KHAKOO, David John KOPECKY, Su-Jen LAI, Zhihua MA, Lawrence R. MCGEE, Julio C. MEDINA, Jeffrey T. MIHALIC, Nobuko NISHIMURA, Steven H. OLSON, Vatee PATTAROPONG, Gayathri SWAMINATH, Xiaodong WANG, Kevin YANG, Wen-Chen YEH, Mikkel V. DEBENEDETTO, Robert P. FARRELL, Simon J. HEDLEY, Ted C. JUDD, Frank KAYSER
  • Publication number: 20170037026
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
    Type: Application
    Filed: October 19, 2016
    Publication date: February 9, 2017
    Inventors: Ning CHEN, Xiaoqi CHEN, Yinhong CHEN, Alan C. CHENG, Richard V. CONNORS, Jeffrey DEIGNAN, Paul John DRANSFIELD, Xiaohui DU, Zice FU, Julie Anne HEATH, Daniel B. HORNE, Jonathan HOUZE, Matthew R. KALLER, Aarif Yusuf KHAKOO, David John KOPECKY, Su-Jen LAI, Zhihua MA, Lawrence R. MCGEE, Julio C. MEDINA, Jeffrey T. MIHALIC, Nobuko NISHIMURA, Steven H. OLSON, Vatee PATTAROPONG, Gayathri SWAMINATH, Xiaodong WANG, Kevin YANG, Wen-Chen YEH, Mikkel V. DEBENEDETTO, Robert P. FARRELL, Simon J. HEDLEY, Ted C. JUDD, Frank KAYSER
  • Patent number: 9558004
    Abstract: A computer-implemented method includes identifying a primary computing platform, identifying one or more secondary computing platforms, and identifying a requesting virtual server. The requesting virtual server resides on the primary computing platform and is associated with one or more requesting clients. One or more donating virtual servers are identified. The donating virtual servers reside on the primary computing platform and are associated with one or more donating clients. One or more external virtual servers are identified. The external virtual servers reside on the secondary computing platforms. A resource donation scenario is determined. The resource donation scenario includes one or more resource exchanges between the requesting virtual server and the donating virtual servers. A resource adjustment scenario is determined. The resource adjustment scenario includes one or more resource exchanges between the external virtual servers.
    Type: Grant
    Filed: October 16, 2015
    Date of Patent: January 31, 2017
    Assignee: International Business Machines Corporation
    Inventors: Victor G. Alonzo, Yuk L. Chan, Gisela C. Cheng, Kin Ng, Vaughn C. Page
  • Patent number: 9536007
    Abstract: A method provides for real-time asset location tracking. An asset in a wide area network, be it a utilities network or a communication network, registers itself with a network management center. The registration process includes identification of a physical location of the asset usable for mapping and tracking the asset.
    Type: Grant
    Filed: June 23, 2009
    Date of Patent: January 3, 2017
    Assignee: AT&T Mobility II LLC
    Inventors: Charles C. Cheng, Xinguo Wei
  • Publication number: 20160376212
    Abstract: Disclosed are (i) a process for making cyclohexylbenzene by benzene hydroalkylation with a low methylcyclopentylbenzene selectivity; and (ii) a process of making phenol and/or cyclohexanone from cyclohexylbenzene including a step of removing methylcyclopentylbenzene from the cyclohexylbenzene feed supplied to the oxidation step.
    Type: Application
    Filed: December 12, 2014
    Publication date: December 29, 2016
    Inventors: Charles Morris Smith, Tan-Jen Chen, Terry E. Helton, Jane C. Cheng
  • Publication number: 20160352100
    Abstract: A vehicle modular power system (VMPS) consisting of a central power distribution module having attached a selectable plurality of first and second side modules and their corresponding termination modules. The modules can be configured with a plurality of electrical power receptacles and/or USB connectors. The central power distribution module also has attached a cigarette lighter plug that is plugged into a vehicle-attached cigarette lighter receptacle that is connected to a vehicle 12-volts d-c power source. When the plug is plugged into the receptacle, the VMPS is enabled.
    Type: Application
    Filed: May 29, 2015
    Publication date: December 1, 2016
    Inventors: John C. Cheng, Joseph S. Chu